Eton Pharmaceuticals (ETON) director exercises options, sells 50,000 shares in open market
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Eton Pharmaceuticals director Jennifer McKie Adams reported an option exercise paired with an open-market sale of common stock. She exercised employee stock options for 50,000 shares of common stock at an exercise price of $3.78 per share, then sold 50,000 shares in open-market transactions at a weighted average price of $32.4759 per share.
The sale was executed in multiple trades at prices ranging from $32.10 to $32.71, and the option grant, which vested quarterly, was fully vested by February 7, 2023. Following these transactions, Adams reported no remaining holdings of common stock or employee stock options.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 50,000 shares ($1,623,795)
Net Sell
3 txns
Insider
Adams Jennifer McKie
Role
null
Sold
50,000 shs ($1.62M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option | 50,000 | $0.00 | -- |
| Exercise | Common Stock | 50,000 | $3.78 | $189K |
| Sale | Common Stock | 50,000 | $32.4759 | $1.62M |
Holdings After Transaction:
Employee Stock Option — 0 shares (Direct, null);
Common Stock — 50,000 shares (Direct, null)
Footnotes (1)
- The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares subject to the option vested on a quarterly basis over 12 months from the date of grant until fully vested on February 7, 2023. The shares were sold in multiple trades at prices ranging from $32.10 to $32.71. The price reported above reflects the weighted average sales price.
Key Figures
Shares sold: 50,000 shares
Weighted average sale price: $32.4759 per share
Sale price range: $32.10–$32.71 per share
+3 more
6 metrics
Shares sold
50,000 shares
Open-market sale of common stock on June 17, 2026
Weighted average sale price
$32.4759 per share
Common stock sales in multiple trades
Sale price range
$32.10–$32.71 per share
Price range across multiple sale trades
Options exercised
50,000 shares
Employee stock option exercise into common stock
Option exercise price
$3.78 per share
Exercise price for employee stock option
Common shares after transaction
0 shares
Reported direct holdings following transactions
Key Terms
open-market sale, derivative exercise/conversion, Employee Stock Option, weighted average sales price, +1 more
5 terms
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
derivative exercise/conversion financial
"transaction_action": "derivative exercise/conversion""
Employee Stock Option financial
""security_title": "Employee Stock Option""
An employee stock option is a promise that lets a worker buy company shares later at a predetermined price, often after they stay for a certain period or meet performance goals — think of it like a coupon that locks in today's price for a future purchase. It matters to investors because options align employees’ incentives with company performance, can increase the number of shares outstanding (dilution) when exercised, and represent a compensation cost that affects reported profits and shareholder value.
weighted average sales price financial
"The price reported above reflects the weighted average sales price."
vested financial
"vested on a quarterly basis over 12 months from the date of grant"
FAQ
What insider transaction did Eton Pharmaceuticals (ETON) director Jennifer McKie Adams report?
Jennifer McKie Adams reported exercising options for 50,000 Eton Pharmaceuticals shares and selling 50,000 shares in open-market trades the same day. This combined exercise-and-sale sequence converted her option position into cash and eliminated her reported holdings.
What was the option exercise price in the Eton Pharmaceuticals (ETON) Form 4 filing?
The employee stock option exercised by Jennifer McKie Adams had an exercise price of $3.78 per underlying share. She exercised options for 50,000 shares of common stock, converting her derivative position into shares before selling those shares in open-market transactions.
Does Jennifer McKie Adams still hold Eton Pharmaceuticals (ETON) common stock after this Form 4?
After the reported transactions, Jennifer McKie Adams reported holding zero shares of Eton Pharmaceuticals common stock. The filing shows 50,000 shares sold and zero shares listed as owned directly following the transaction, indicating a full exit from reported common stock holdings.
When did the employee stock options in the Eton Pharmaceuticals (ETON) Form 4 fully vest?
The employee stock options fully vested on February 7, 2023. The footnote explains the options vested on a quarterly basis over 12 months from the grant date until they became fully vested on that February 7, 2023 vesting date.